Memorial Hospital Research Laboratories
The Andrew Kung Lab
Research

The Kung Lab leverages patient-driven discovery to identify drivers and therapeutic vulnerabilities in pediatric and young adult cancers. The research infrastructure of the lab bridges the clinic, dry lab, and wet lab, with experimental data derived from model systems as well as in-human studies. We have developed a variety of experimental platforms to support the preclinical evaluation of promising agents including capabilities for in vitro drug screening, cell line development from patient tumor tissue, and in vivo testing in patient-derived xenograft (PDX) models. We have embraced computational biology approaches to predict genomically and non-genetically encoded tumor vulnerabilities, and utilize preclinical models to validate these therapeutic hypotheses.
Featured News

Publications Highlights
People

Andrew Kung, MD, PhD
Chair, Department of Pediatrics
- MD, Stanford University School of Medicine
Members


















Preclinical and Lab Program Lead

PDX Program Lead

Assistant Attending, AYA Preclinical Lead

Research Lab Manager & Drug Screen Program Lead

Cell Line Generation Program Lead

Research Associate

PROXC PDX Consortium Program Manager

Drug Formulation & Lab Operations

Data Manager

Instructor, Clinical Translation Investigator

Sr Animal Technician

Research Assistant

Animal Technician

Animal Technician

Sr Research Technician

Clinical Fellow

Assistant Attending Pediatrician

Animal Technician
Lab Affiliations
Open Positions
To learn more about available postdoctoral opportunities, please visit our Career Center
To learn more about compensation and benefits for postdoctoral researchers at MSK, please visit Resources for Postdocs